Breast Neoplasms: all 12,828 studies

Page 64 of 129. Open to participants first (2,932), then studies with results posted, then the rest; newest registration first within each.

• The Effects of a Nurse-led MHealth Program for Symptom Self-management of Breast Cancer Patients Undergoing ChemotherapyCompletedNCT05192525Not applicable
• Clinical Study of Fulvestrant Combined With Chidamide in the Treatment of Hormone Receptor-positive Advanced Breast Cancer Resistant to CDK4/6 InhibitorsStatus unknownNCT05191914Phase 4
• Study of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBCWithdrawnNCT05191004Phase 1/2
• "Prevention of Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients"CompletedNCT05189535Phase 2/3
• Trastuzumab(Henlius®) Combined With Pertuzumab(Perjeta®) and Chemotherapy in Chinese Patients With Her2-Positive Metastatic Breast Cancer Previously Treated With TrastuzumabStatus unknownNCT05188495
• Comparative Analysis of Three Locoregional Anesthesia Methods in Breast Tumour Pathology SurgeryCompletedNCT05185752Not applicable
• Zoladex® 10.8 BC RWSCompletedNCT05184257
• Evaluating the Use of Patient Navigation to Promote Timely Diagnostic Evaluation During the COVID-19 PandemicCompletedNCT05181722Not applicable
• Biomarkers of Liposomal Doxorubicin Induced Hypersensitivity Reaction in Breast Cancer PatientsStatus unknownNCT05181202
• DLSCT for Breast Cancer Detection in Women With Dense BreastsStatus unknownNCT05181059
• Safety and Efficacy of Recombinant Oncolytic Adenovirus L-IFN Injection in Relapsed/Refractory Solid Tumors Clinical StudyStatus unknownNCT05180851Early Phase 1
• Feasibility of a Remotely-Delivered Yoga Intervention on Cognitive Function in Breast Cancer SurvivorsCompletedNCT05180656Not applicable
• GEN1047 for Solid Tumors - First in Human (FIH) TrialTerminatedNCT05180474Phase 1/2
• Impact of Neoadjuvant Immunotherapy in Early Stage Breast Cancer Before Standard TherapyTerminatedNCT05180006Phase 2
• Aesthetic Outcomes of Oncoplastic Breast Surgery for Breast Cancer in the Upper Inner QuadrantStatus unknownNCT05179304Not applicable
• Panitumumab and Pembrolizumab in Combination With Neoadjuvant Chemotherapy for the Treatment of Stage III-IV Triple Negative Breast CancerWithdrawnNCT05177796Phase 2
• RCT of Strategies to Augment Physical Activity in Black and Hispanic Breast and Prostate Cancer Survivors (ALLSTAR)CompletedNCT05176756Not applicable
• Famitinib Plus SHR6390 and Endocrine Therapy in the Treatment of HR-positive, HER2-negative Advanced Breast CancerTerminatedNCT05176080Phase 1/2
• Induction of Cisplatin/Nab-paclitaxel/Pembrolizumab Followed by Olaparib/Pembrolizumab Maintenance in mTNBC PatientsStatus unknownNCT05174832Phase 2
• Marker Technique Comparison in Targeted Axillary DissectionCompletedNCT05173415Not applicable
• Programmed Death-Ligand1 Expression in Her-2 Positive and Triple Negative Breast CancerActive, not recruitingNCT05169853
• The Effect of Virtual Reality on Anxiety and Fatigue in Women With Breast Cancer Receiving Adjuvant ChemotherapyCompletedNCT05168696Not applicable
• H (Trastuzumab or Biosimilar) Combined With CDK4/6 Inhibitor + AI±OFS in the Treatment of HR+HER2+ Advanced Breast Cancer Efficacy and Safety: a Chinese Multi-center Real World StudyStatus unknownNCT05167643Not applicable
• Consequences of Eccentric Cycling on Exercise-related Neuromuscular Responses and Biomarkers in Breast Cancer PatientsCompletedNCT05166148Not applicable
• Phase II Neoadjuvant Pyrotinib Combined With Neoadjuvant Chemotherapy in HER2-low-expressing and HR Positive Early or Locally Advanced Breast Cancer: a Single-arm, Non-randomized, Single-center, Open Label TrialActive, not recruitingNCT05165225Phase 2
• The Efficacy and Safety of Mecobalamin in the Prevention of Capecitabine Induced Hand Foot SyndromeActive, not recruitingNCT05165069Phase 3
• Delayed Versus Immediate Use Of Zoledronic Acid For Postmenopausal Patients With Early Breast Cancer Who Are Using Adjuvant LetrozoleStatus unknownNCT05164952Phase 3
• A Randomized Cluster Trial to Evaluate a Mobile Mammography Unit in Breast Cancer Screening in France (Mammobile)Status unknownNCT05164874Not applicable
• Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Patients With Breast CancerTerminatedNCT05163223Phase 2
• Neoadjuvant Treatment of Locally-advanced Breast Cancer Patients With Ribociclib and LetrozoleCompletedNCT05163106Phase 2
• Magseed and Magtrace Localization for Breast CancerCompletedNCT05161507
• A Guided Online Intervention to Improve Quality of Life in Breast Cancer Patients - a Randomised Clinical TrialCompletedNCT05161312Not applicable
• Roll-over Study to Allow Continued Access to RibociclibActive, not recruitingNCT05161195Phase 4
• A Study of GNC-035, a Tetra-specific Antibody, in Participants With Locally Advanced or Metastatic Breast CancerActive, not recruitingNCT05160545Phase 1
• T1-T2 Breast Cancer: Comparison Between Removal and Preservation of Axillary Lymph Nodes (SINODAR ONE)Active, not recruitingNCT05160324Not applicable
• Phase 2 Study of Imprime PGG and Pembrolizumab in Patients With HR+/HER2- Metastatic Breast Cancer (mBCA)CompletedNCT05159778Phase 2
• A Study of PRT2527 in Participants With Advanced Solid TumorsCompletedNCT05159518Phase 1
• Quantitative Assessment of Diffusion Spectrum Imaging in Breast CancerStatus unknownNCT05159323Not applicable
• Development of a Genetic Counseling Patient Preference Intervention for Women at Elevated Risk for Breast CancerCompletedNCT05158452
• Testosterone & Tamoxifen TrialTerminatedNCT05156606Not applicable
• Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic MalignancyStatus unknownNCT05154474
• Neratinib Dose Escalation Regimen for HER2 Positive Early Breast CancerStatus unknownNCT05154396Phase 2
• Description of Treatment Patterns and Description and Comparison of Healthcare Resource Utilization and Costs of Women With Metastatic HR+/HER2- Breast Cancer Treated With CDK4/6 InhibitorsCompletedNCT05153135
• Circulating microRNA 21 Expression Level Before and After Neoadjuvant Systemic Therapy in Breast CarcinomaStatus unknownNCT05151224
• Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast CancerCompletedNCT05150652Phase 2
• One Week Adjuvant Radiotherapy for Breast CancerStatus unknownNCT05150535Not applicable
• Safety, Effectiveness and Quality of Life of Trastuzumab Deruxtecan in Patients with HER2+ Breast CancerCompletedNCT05149014
• Breast Cancer and Intrauterine ContraceptionStatus unknownNCT05148910Not applicable
• The Impact of Chronic Mitochondrial Antioxidant Supplementation on CardiovascularToxicity in Breast Cancer PatientsStatus unknownNCT05146843Not applicable
• Diversity and Inclusion in Research Underpinning Prevention and Therapy TrialsCompletedNCT05146297Not applicable
• A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid TumorsActive, not recruitingNCT05143970Phase 1
• Alpelisib And Sacituzumab Govitecan For Treatment Of Breast CancerActive, not recruitingNCT05143229Phase 1
• High Five (HiFi) Accelerated Partial Breast Irradiation StudyActive, not recruitingNCT05142202Not applicable
• Axillary Sentinel or Targeted Lymph Node Biopsy Alone After Neoadjuvant Chemotherapy in Node-positive Breast CancerStatus unknownNCT05141630Phase 2
• Accuracy Of Contrast Enhanced Mamography in Predicting Response of Breast Cancer Post Neoadjuvant ChemotherapyStatus unknownNCT05141279
• A Real-world Analysis of Concomitant Medication Use Among Metastatic Breast Cancer Patients Treated With CDK4/6 InhibitorsCompletedNCT05141240
• Effectiveness and Safety of Fulvestrant in Postmenopausal Women With Advanced Breast Cancer HR+, HER2-Status unknownNCT05140655
• Avoiding Low-value Treatments in Older Women With Early-stage Breast Cancer: Piloting a Patient Decision AidCompletedNCT05140252Not applicable
• The Effect of Oral Cryotherapy on Anticipatory, Acute and Late Nausea and Vomiting in Breast Cancer PatientsCompletedNCT05138627Not applicable
• Sexual Health in Breast Cancer PatientsCompletedNCT05138510
• Chemotherapy - Induced Peripheral NeuropathyCompletedNCT05138042Not applicable
• Study Of Real-World Evidence In Patients Treated With Palbociclib During a 2.5 Years Follow-Up PeriodStatus unknownNCT05135104
• The Association of Hormonal Intake and Demographic Factors With Breast Cancer Risk. An Egyptian Case-controlled StudyStatus unknownNCT05135013
• A Study of Camrelizumab in Combination With Chemotherapy Regimen Comparative Chemotherapy Regimen for Metastatic Triple-negative Breast CancerTerminatedNCT05134194Phase 3
• Therapeutic Dose Monitoring (TDM) of TamoxifenStatus unknownNCT05133674Phase 2
• Breast Cancer Study of Stereotactic Body Radiation Therapy (SBRT) Combined Neoadjuvant TreatmentActive, not recruitingNCT05132790Not applicable
• Mobile-Health Delivery of Lifestyle Interventions for Women With Breast CancerActive, not recruitingNCT05132296Not applicable
• Analysis of the Real-world Prescription Pattern of Palbociclib Combination Therapy With Aromatase Inhibitor as a First Line Therapy in Metastatic Breast Cancer Patients Using the National Health Insurance Claims Data in South KoreaCompletedNCT05132101
• Cipterbin Combined With Vinorelbine in the Treatment of HER2-positive MBCStatus unknownNCT05131841Phase 4
• The BurnAlong Pilot Study for Adolescent and Young Adult Cancer SurvivorsCompletedNCT05131815Not applicable
• Monitoring for Cancer Spread to the Central Nervous System (CNS) in People With Breast CancerActive, not recruitingNCT05130840Not applicable
• Patient-Specific Decision Aid System for Shared Decision Making About Breast ReconstructionActive, not recruitingNCT05130580Not applicable
• Acute Effects of Chemotherapy Administration on Skeletal Muscle of Breast Cancer Patients: the PROTECT-06 StudyCompletedNCT05128617
• Analysis of Breast-Conserving Surgery Plus Whole-Breast Irradiation Versus MastectomyCompletedNCT05126667
• Genetic Predictors to Acupuncture Response for Arthralgia Induced by Aromatase Inhibitors in Patients With Breast CancerStatus unknownNCT05125432Not applicable
• Magnetic Tracer in the Sentinel Node Procedure in Breast Cancer: the Non-radioactive Alternative for Radio-isotopesCompletedNCT05122585Not applicable
• RWE About QOL and Compliance of Patients With OFS in ChinaCompletedNCT05122377
• Brain Imaging, Nutrition, and Cognition in Breast Cancer SurvivorsCompletedNCT05122000
• Effect of ALND With Vein Branches Reservation on Postoperative Upper Limb Edema and Dysfunction in Breast CancerActive, not recruitingNCT05120180Not applicable
• Efficacy of Aquatic Physiotherapy in the Treatment of Upper Limb Lymphedema in Women With Breast Cancer.CompletedNCT05119049Not applicable
• Assessment of Lumpectomy Margins With the Histolog Scanner in Comparison With Intraoperative Imaging TechniquesCompletedNCT05118568
• Moxifloxacin in Adjuvant Treatment of Patients With Operable Breast CancerCompletedNCT05114720Phase 3
• Analysis of Patient Understanding of Radiation Therapy Among Patients With Breast CancerCompletedNCT05114525Not applicable
• UCLA Breast Cancer Survivor Health Promotion Research StudyStatus unknownNCT05113485Not applicable
• Adjuvant Whole Breast Irradiation in Five Fractions Versus Fifteen Fractions in Early Breast CancerStatus unknownNCT05112341
• Molecular Subtyping of Triple-negative Breast Cancer and African Ancestry-related ImmunogenicityCompletedNCT05111067
• Efficacy and Safety of LY01005 in Patients With Breast Cancer Compared to ZOLADEX®CompletedNCT05110170Phase 3
• MAP Treatment Plan With Afinitor for Postmenopausal Women With Advanced HR+ Breast CancerNo longer availableNCT05108740
• Continuous Glucose Monitoring Profile Description Under Alpelisib treAtment in Patients With Advanced bREast CancerStatus unknownNCT05107388Not applicable
• Financial Toxicity in Breast Cancer SurgeryActive, not recruitingNCT05104632
• A Study to Assess the Safety, Tolerability and Antitumor Activity of X4P-001 in Combination With TNBCStatus unknownNCT05103917Phase 1/2
• A Study of SHR6390 Combined With Famitinib in the Treatment of ER + / HER2- Advanced Breast CancerTerminatedNCT05103826Phase 1
• Study of the Therapeutic Effect of Atorvastatin on the Clinical Outcomes in HER2 Negative Breast Cancer Patients"Status unknownNCT05103644Phase 2/3
• PTC Guiding Neoadjuvant Treatment in Breast CancerCompletedNCT05103293Phase 2
• Second Opinions in OncologyCompletedNCT05102500
• Evaluation of the Effects of the Couple-based Family Nursing for Women With Breast CancerCompletedNCT05100914Not applicable
• Web-based Oncofertility Support Tool for Reproductive-age Women With Breast CancerCompletedNCT05100498Not applicable
• Impact of Oncotype DX® on Treatment Recommendation and Its Economic Evaluation Under the Brazilian Society PerspectiveCompletedNCT05100277
• Precision Acupuncture in the Treatment of Peripheral Neuropathy After Taxanes Chemotherapy in Breast CancerStatus unknownNCT05099562Not applicable
• Acupuncture for Stiffness of Joint Related to Aromatase Inhibitors in Patients With Early-Stage Breast CancerStatus unknownNCT05098951Not applicable

← Breast Neoplasms overview